Orange Book product · Brand (NDA)
PATADAY ONCE DAILY RELIEF
OLOPATADINE HYDROCHLORIDE
At a glance
Jan 30, 2015
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 30, 2015
11 yr 7 mo ago
Today
Patent 8791154 expires
Listed drug product patent expiration.
May 19, 2032
in 6 yr
Patent 9533053 expires
Listed drug product patent expiration.
May 19, 2032
in 6 yr
Pharmaceutical detail
Active ingredient
OLOPATADINE HYDROCHLORIDE
Strength
EQ 0.7% BASE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 206276
Product number
001
Marketing status
OTC
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2008PATANASEBrand (NDA)
NDA 021861 · NOVARTIS
- 2004PATADAY ONCE DAILY RELIEFBrand (NDA)
NDA 021545 · ALCON LABS INC
- 1996PATADAY TWICE DAILY RELIEFBrand (NDA)
NDA 020688 · ALCON LABS INC
- 2026OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213514 · GLAND
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217051 · FDC LTD
- 2025OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219557 · GLENMARK PHARMS
- 2024OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215006 · SOMERSET
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213757 · HIKMA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204620 · RISING
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209752 · GLAND
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208637 · FLORIDA
- 2020OLOPATADINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210901 · AMNEAL
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8791154 | May 19, 2032 | in 6 yr | ProductU-1680 |
| 9533053 | May 19, 2032 | in 6 yr | Product |

